太平洋生物科学 PACB
$2.26 −$0.18 (-7.20%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $2.25 -0.14%
开盘$2.43
昨收$2.43
当日区间$2.24 – $2.54
成交量9.56M
市值$705.65M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$39.01M-1.9% YoY
营业利润-$44.61M+0.5% YoY
净利润-$44.74M-6.7% YoY
摊薄每股收益-$0.14+0.0% YoY
自由现金流-$39.19M-31.0% YoY
经营现金流-$35.58M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率36.4%
营业利润率-102.6%
净利率-82.5%
净资产收益率-929.3%
资产收益率-16.7%
投入资本回报率-17.7%
流动比率4.92
负债/资产比率104.4%
现金及投资$236.87M
总负债$704.76M
净现金（净负债）-$467.88M
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $39.01M | $37.18M | $160.01M | $44.65M | $38.44M |
| 营业总收入 | $39.01M | $37.18M | $160.01M | $44.65M | $38.44M |
| 营业成本 | $26.37M | $24.34M | $114.23M | $28.08M | $22.54M |
| 毛利润 | $12.64M | $12.84M | $45.78M | $16.57M | $15.90M |
| 营业费用 | $57.25M | $66.99M | $603.34M | $57.76M | $54.78M |
| 销售及管理费用 | $33.39M | $31.15M | $141.49M | $34.05M | $31.10M |
| 研发费用 | $23.02M | $19.61M | $97.31M | $22.88M | $22.85M |
| 折旧、摊销与折耗 | $833,000.00 | $833,000.00 | $364.54M | $833,000.00 | $833,000.00 |
| -折旧与摊销 | $833,000.00 | $833,000.00 | $364.54M | $833,000.00 | $833,000.00 |
| 营业利润 | -$44.61M | -$54.15M | -$557.56M | -$41.20M | -$38.88M |
| 非经营性利息净收入（支出） | -$2.11M | -$1.74M | -$6.95M | -$1.74M | -$1.74M |
| 非经营性利息支出 | $2.11M | $1.74M | $6.95M | $1.74M | $1.74M |
| 其他收入（支出） | $2.04M | $47.80M | $18.46M | $2.77M | $3.00M |
| 特殊收益（费用） | $0.00 | $45.80M | $3.70M | $0.00 | $0.00 |
| -减：重组及并购费用 | $0.00 | $0.00 | -$18.70M | $0.00 | $0.00 |
| -减：核销 | $0.00 | $0.00 | $15.00M | $0.00 | $0.00 |
| -固定资产出售收益 | $0.00 | $45.80M | – | – | – |
| 其他非经营性收入（支出） | $2.04M | $2.01M | $14.76M | $2.77M | $3.00M |
| 税前利润 | -$44.68M | -$8.09M | -$546.06M | -$40.17M | -$37.62M |
| 税费 | $58,000.00 | $184,000.00 | $318,000.00 | $202,000.00 | $383,000.00 |
| 净利润 | -$44.74M | -$8.28M | -$546.38M | -$40.37M | -$38.00M |
| 持续经营利润 | -$44.74M | -$8.28M | -$546.38M | -$40.37M | -$38.00M |
| 归属母公司净利润 | -$44.74M | -$8.28M | -$546.38M | -$40.37M | -$38.00M |
| 归属普通股股东净利润 | -$44.74M | -$8.28M | -$546.38M | -$40.37M | -$38.00M |
| 基本每股收益 | -$0.14 | -$0.03 | -$1.82 | -$0.13 | -$0.13 |
| 摊薄每股收益 | -$0.14 | -$0.03 | -$1.82 | -$0.13 | -$0.13 |
| 其他营业费用 | – | $15.40M | – | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $751.85M | $782.37M | $784.08M | $784.08M | $803.16M |
| 流动资产合计 | $338.64M | $369.52M | $375.05M | $375.05M | $394.24M |
| 现金及现金等价物与短期投资 | $236.87M | $275.96M | $279.51M | $279.51M | $298.65M |
| -现金及现金等价物 | $61.00M | $56.27M | $63.71M | $63.71M | $56.47M |
| -短期投资 | $175.87M | $219.69M | $215.80M | $215.80M | $242.19M |
| 应收款 | $31.10M | $29.35M | $35.45M | $35.45M | $30.62M |
| -应收账款 | $31.10M | $29.35M | $35.45M | $35.45M | $30.62M |
| 存货 | $61.08M | $51.02M | $49.29M | $49.29M | $53.15M |
| 受限现金 | $33,000.00 | $19,000.00 | $20,000.00 | $20,000.00 | $300,000.00 |
| 其他流动资产 | $9.55M | $13.16M | $10.79M | $10.79M | $11.51M |
| 非流动资产合计 | $413.21M | $412.85M | $409.03M | $409.03M | $408.92M |
| 固定资产净值 | $67.30M | $65.22M | $65.84M | $65.84M | $64.71M |
| -固定资产原值 | $67.30M | $65.22M | $158.31M | $158.31M | $64.71M |
| 商誉及其他无形资产 | $330.85M | $331.87M | $332.89M | $332.89M | $333.90M |
| -商誉 | $317.76M | $317.76M | $317.76M | $317.76M | $317.76M |
| -其他无形资产 | $13.08M | $14.10M | $15.12M | $15.12M | $16.14M |
| 其他非流动资产 | $15.06M | $15.76M | $10.31M | $10.31M | $10.31M |
| 负债合计 | $785.06M | $780.00M | $778.73M | $778.73M | $767.07M |
| 流动负债合计 | $68.81M | $65.36M | $72.83M | $72.83M | $63.21M |
| 应付款 | $19.22M | $13.61M | $20.77M | $20.77M | $16.36M |
| -应付账款 | $19.22M | $13.61M | $20.77M | $20.77M | $16.36M |
| 一年内应计费用 | $30.32M | $33.90M | $33.65M | $33.65M | $29.17M |
| 短期债务及融资租赁负债 | $1.37M | $277,000.00 | $448,000.00 | $448,000.00 | $621,000.00 |
| -一年内到期融资租赁负债 | $1.37M | $277,000.00 | $448,000.00 | $448,000.00 | $621,000.00 |
| 一年内递延负债 | $16.10M | $16.33M | $15.94M | $15.94M | $16.05M |
| 其他流动负债 | $1.79M | $1.24M | $654,000.00 | $654,000.00 | $1.01M |
| 非流动负债合计 | $716.26M | $714.64M | $705.90M | $705.90M | $703.86M |
| 长期债务及融资租赁负债 | $704.76M | $703.11M | $701.97M | $701.97M | $699.46M |
| -长期债务 | $644.33M | $644.11M | $645.38M | $645.38M | $645.16M |
| -长期融资租赁负债 | $60.42M | $59.00M | $56.59M | $56.59M | $54.30M |
| 一年以上递延负债 | $3.34M | $3.55M | $3.93M | $3.93M | $4.40M |
| 其他非流动负债 | $8.16M | $7.98M | – | – | – |
| 股东权益合计 | -$33.21M | $2.37M | $5.35M | $5.35M | $36.09M |
| 股东权益 | -$33.21M | $2.37M | $5.35M | $5.35M | $36.09M |
| 股本 | $311,000.00 | $311,000.00 | $302,000.00 | $302,000.00 | $302,000.00 |
| -普通股 | $311,000.00 | $311,000.00 | $302,000.00 | $302,000.00 | $302,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.72B | $2.71B | $2.70B | $2.70B | $2.69B |
| 留存收益 | -$2.75B | -$2.70B | -$2.70B | -$2.70B | -$2.65B |
| 不影响留存收益的损益 | -$503,000.00 | -$147,000.00 | $457,000.00 | $457,000.00 | $415,000.00 |
| -累计折旧 | – | – | -$92.47M | -$92.47M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$35.58M | -$44.69M | -$111.21M | -$19.07M | -$18.71M |
| 持续经营经营活动现金流净额 | -$35.58M | -$44.69M | -$111.21M | -$19.07M | -$18.71M |
| 持续经营净利润 | -$44.74M | -$8.28M | -$546.38M | -$40.37M | -$38.00M |
| 持续经营损益 | $0.00 | -$48.10M | – | – | – |
| 折旧、折耗与摊销 | $4.52M | $4.07M | $386.41M | $4.65M | $4.40M |
| 递延税款 | $0.00 | $0.00 | -$546,000.00 | $0.00 | $0.00 |
| 其他非现金项目 | $225,000.00 | $225,000.00 | -$17.01M | $232,000.00 | $397,000.00 |
| 营运资金变动 | -$5.99M | $3.17M | $4.44M | $7.49M | $3.21M |
| -应收款变动 | -$1.75M | $6.10M | -$7.92M | -$4.83M | $1.64M |
| -存货变动 | -$11.26M | -$3.21M | -$1.42M | $3.51M | -$1.06M |
| -预付资产变动 | $1.86M | -$2.29M | $8.51M | $717,000.00 | $988,000.00 |
| -应付账款及应计费用变动 | $3.40M | -$4.01M | $5.64M | $6.28M | $2.28M |
| -其他流动负债变动 | $2.20M | $6.56M | -$470,000.00 | $2.41M | -$518,000.00 |
| -其他营运资金变动 | -$442,000.00 | $19,000.00 | $101,000.00 | -$584,000.00 | -$123,000.00 |
| 投资活动现金流净额 | $40.07M | $35.86M | $115.45M | $26.03M | $18.90M |
| 持续经营投资活动现金流净额 | $40.07M | $35.86M | $115.45M | $26.03M | $18.90M |
| 固定资产购置及出售净额 | -$1.56M | -$3.04M | -$2.71M | -$861,000.00 | $86,000.00 |
| 无形资产购置及出售净额 | -$2.06M | -$5.00M | -$5.00M | $0.00 | $0.00 |
| 投资购置及出售净额 | $43.68M | -$4.20M | $123.16M | $26.89M | $18.82M |
| 其他投资变动净额 | $0.00 | $48.10M | – | – | – |
| 筹资活动现金流 | $255,000.00 | $1.44M | $3.43M | $0.00 | $1.47M |
| 持续经营筹资活动现金流净额 | $255,000.00 | $1.44M | $3.43M | $0.00 | $1.47M |
| 股票期权行使所得 | $255,000.00 | $1.44M | $3.43M | $0.00 | $1.47M |
| 期末现金余额 | $62.61M | $56.27M | $65.26M | $65.26M | $58.30M |
| 现金净变动 | $4.74M | -$7.40M | $7.67M | $6.96M | $1.66M |
| 期初现金余额 | $56.27M | $65.26M | $57.59M | $58.30M | $56.64M |
| 自由现金流 | -$39.19M | -$52.73M | -$118.92M | -$19.93M | -$18.62M |
| 业务购买及出售净额 | – | – | $0.00 | – | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
| 普通股发行净额 | – | – | $0.00 | – | – |
暂无评论——快来第一个聊聊 PACB。